Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

NCT00626327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1630

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infections

Interventions

BIOLOGICAL: MenACWY-CRM + MMRV
BIOLOGICAL: MMRV
BIOLOGICAL: MenACWY-CRM

Sponsor

Novartis Vaccines